Inventor

Jesse M. Cedarbaum

Inventor
Larchmont, NY, US

Overview

16→
Patents
2003–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 16 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07KPeptides28%
PatentTitleYear
10,272,082Combination ALS therapy20198,748,496'Methods of treatment of hyperuricemia and associated disease states'20148,388,963'Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof'20137,531,172'Methods of treating diseases with a VEGF antagonist'20097,482,002'Method of administering and using VEGF inhibitors for the treatment of prostate cancer'20097,482,001'Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer'20097,479,273'Method of administering and using VEGF inhibitors for the treatment of renal cell cancer'20097,479,272'Method of administering and using VEGF inhibitors for the treatment of breast cancer'20097,479,275'Method of administering and using VEGF inhibitors for the treatment of colorectal cancer'20097,479,274'Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma'20097,449,182'Therapeutic combination of a VEGF antagonist and anti-hypertensive agent'20087,354,580'Method of administering and using VEGF inhibitors for the treatment of human cancer'20087,354,582'Use of VEGF antagonists for the treatment of malignant gliomas'20087,354,581'Therapeutic combination of a VEGF antagonist and anti-hypertensive agent'20087,351,411'Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)'20086,656,474'Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2013Patents assigned to REGENERON PHARMA (13)· patent assignee history
2003–2013Based in Larchmont, NY, US· patent location history
2009–2014Patents assigned to CEDARBAUM JESSE M (3)· patent assignee history
2013Patents assigned to AVENTIS PHARMA SA (1)· patent assignee history
2013Patents assigned to BISSERY MARIE-CHRISTINE (1)· patent assignee history
2014–2019Based in San Francisco, CA, US· patent location history
2019Patents assigned to CEDARBAUM JESSE (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REGENERON PHARMA132003–2013
CEDARBAUM JESSE Mself32009–2014
AVENTIS PHARMA SA12013
BISSERY MARIE-CHRISTINE12013
CEDARBAUM JESSEself12019
Locations
LocationPatentsSpan
Larchmont, New York, US142003–2013
San Francisco, California, US22014–2019